Intended for healthcare professionals

CCBYNC Open access
Research Methods & Reporting

How to design efficient cluster randomised trials

BMJ 2017; 358 doi: https://doi.org/10.1136/bmj.j3064 (Published 14 July 2017) Cite this as: BMJ 2017;358:j3064
  1. K Hemming, senior lecturer1,
  2. S Eldridge, professor of biostatistics2,
  3. G Forbes, statistician2,
  4. C Weijer, professor3,
  5. M Taljaard, senior scientist45
  1. 1Institute of Applied Health Research, University of Birmingham, Birmingham B15 2TT, UK
  2. 2Pragmatic Clinical Trials Unit, Centre for Primary Care and Public Health, Queen Marys University, London, UK
  3. 3Rotman Institute of Philosophy, Western University, London N6A 5B8, Canada
  4. 4Clinical Epidemiology Program, Ottawa Hospital Research Institute, 1053 Carling Avenue, Ottawa, Ontario, K1Y4E9, Canada
  5. 5School of Epidemiology, Public Health and Preventive Medicine, University of Ottawa, Ottawa, Ontario, Canada
  1. Correspondence to: K Hemming k.hemming{at}bham.ac.uk
  • Accepted 5 June 2017

Cluster randomised trials have diminishing returns in power and precision as cluster size increases. Making the cluster a lot larger while keeping the number of clusters fixed might yield only a very small increase in power and precision, owing to the intracluster correlation. Identifying the point at which observations start making a negligible contribution to the power or precision of the study—which we call the point of diminishing returns—is important for designing efficient trials. Current methods for identifying this point are potentially useful as rules of thumb but don’t generally work well. We introduce several practical aids to help researchers design cluster randomised trials in which all observations make a material contribution to the study. Power curves enable identification of the point at which observations begin to make a negligible contribution to a study for a given target difference. Under this paradigm, the number needed per arm under individual randomisation gives an upper bound on the cluster size, which should not be exceeded. Corresponding precision curves can be useful for accommodating flexibility in the choice of target difference and show the point at which confidence intervals around the estimated effect size no longer decrease. To design efficient trials, the number of clusters and cluster size should be determined concurrently, not independently. Funders and researchers should be aware of diminishing returns in cluster trials. Researchers should routinely plot power or precision curves when performing sample size calculations so that the implications of cluster sizes can be transparent. Even when data appear to be “free,” in the sense that few resources are needed to obtain the data, excessive cluster sizes can have important ramifications

Summary points

  • Cluster randomised trials have diminishing returns in power and precision as cluster size increases

  • In some situations a small increase in the number of clusters can lead to …

View Full Text